Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China NT Pharma Group CoHKSE:01011 -6.67%1 Days Payable is 69.31 as of Dec. 2025, which is 57% below its 10-year median of 160.53. GuruFocus rates HKSE:01011 with a GF Score™ of 1/100. The stock has 4 warning signs investors should review. Among 925 Drug Manufacturers companies, China NT Pharma Group Co ranks worse than 70.16% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, China NT Pharma Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China NT Pharma Group Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China NT Pharma Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where China NT Pharma Group Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
China NT Pharma Group Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China NT Pharma Group Co (HKSE:01011) has a Days Payable of 69.31 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China NT Pharma Group Co and its competitors. This is 57% below median its historical median of 160.53. Over the past decade, China NT Pharma Group Co's Days Payable has ranged from 8.35 to 291.91. According to the industry distribution chart, China NT Pharma Group Co ranks #649 out of 925 companies in the Drug Manufacturers industry, placing it in the top 70.2%.
Is China NT Pharma Group Co's Days Payable too high?
China NT Pharma Group Co's current Days Payable of 69.31 is 57% below median its 10-year median of 160.53. Over the past 10 years, this metric has ranged from a low of 8.35 to a high of 291.91. The Drug Manufacturers industry median Days Payable is 89.70. China NT Pharma Group Co's value of 69.31 is 22.7% below this industry median. Based on the distribution chart, China NT Pharma Group Co ranks #649 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, China NT Pharma Group Co has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does China NT Pharma Group Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China NT Pharma Group Co ranks #649 out of 925 companies for Days Payable. This places China NT Pharma Group Co in the lower half of its industry. The industry median Days Payable is 89.70. China NT Pharma Group Co's value of 69.31 is 22.7% below this benchmark. Historically, China NT Pharma Group Co's own Days Payable has ranged from 8.35 to 291.91 over the past decade. While the company's 10-year median is 160.53 vs. the industry median of 89.70, China NT Pharma Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 89.70, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China NT Pharma Group Co's current Days Payable of 69.31 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China NT Pharma Group Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 89.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China NT Pharma Group Co's current Days Payable is 69.31, which is 57% below median its own 10-year median of 160.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China NT Pharma Group Co stock overvalued right now?
China NT Pharma Group Co (HKSE:01011) has a current Days Payable of 69.31. The current Days Payable is 69.31, which is 57% below median its 10-year median of 160.53 and 22.7% below the Drug Manufacturers industry median of 89.70. China NT Pharma Group Co's overall GF Score™ is 1/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For China NT Pharma Group Co (HKSE:01011), the current Days Payable is 69.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The Group's operations are regarded as having two operating and reportable segments, namely Agency Services and Healthcare Related Services. The company generates maximum of its revenue from Healthcare Related Services.
1GF Score
Get the complete analysis for HKSE:01011
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01011 has been successfully added to your 
